Hutchmed (HCM) is up 10.4%, or $1.70 to $18.07.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCM:
- Hutchmed’s Phase III Study on HMPL-306: A Potential Game-Changer for AML Treatment
- HUTCHMED (China) Buy Rating: Strategic Growth Amidst Market Challenges
- Hutchmed Reports Strong Interim Results Amid Strategic Growth
- Hutchmed reports 1H EPS $2.61 vs. 15c last year
- Hutchmed sees FY25 Oncology/Immunology revenue $270M-$350M